Galderma R&d

This study tests a drug called nemolizumab in 162 adults with systemic sclerosis, a disease that causes skin thickening and can harm internal organs. Participants receive either nemolizumab or a placebo as a shot under the skin for 52 weeks. The main goal is to see if the drug re…

This study is tracking 1,000 adolescents and adults with moderate-to-severe atopic dermatitis (eczema) who are starting treatment with nemolizumab (Nemluvio®) in real-world clinics. The main goal is to see how well the drug controls skin symptoms and itching after 6 months, using…

This study looks at how well the drug nemolizumab works for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. Researchers will track 600 participants over 6 months in real-world clinics, measuring itch severity and skin lesi…

This Phase 2 study tests a drug called nemolizumab in 50 adults with chronic itching that has no known cause. The goal is to see how the drug works in the body and whether it can reduce itching over 16 weeks. Participants receive either nemolizumab or a placebo injection.

This study tests Sculptra injections to improve cheek wrinkles and skin looseness in 25 women aged 45-65. Participants receive up to three treatments, and researchers use special cameras to measure skin changes over time. The goal is to see if this cosmetic procedure works and ho…

This study tests a cream called trifarotene on Chinese people aged 9 and older with moderate acne on the face and upper body. About 561 participants will apply the cream or a placebo daily for 12 weeks. The goal is to see if the cream reduces acne lesions and improves skin appear…

This study looks at how a treatment called poly L-lactic acid (PLLA) changes proteins in the skin of menopausal women with cheek wrinkles. About 40 women will receive the treatment, and small skin samples will be taken to measure these changes. The goal is to understand how the t…